Literature DB >> 31951916

Caenorhabditis elegans as a model system for human diseases.

Maria Markaki1, Nektarios Tavernarakis2.   

Abstract

The nematode Caenorhabditis elegans offers unique advantages that enable a comprehensive delineation of the cellular and molecular mechanisms underlying devastating human pathologies such as stroke, ischemia and age-associated neurodegenerative disorders. Genetic models of human diseases that closely simulate several disease-related phenotypes have been established in the worm. These models allow the implementation of multidisciplinary approaches, in addition to large-scale genetic and pharmacological screenings, designed to elucidate the molecular mechanisms mediating pathogenesis and to identify targets and drugs for emergent therapeutic interventions. Such strategies have already provided valuable insights, highly relevant to human health and quality of life. This article considers the potential of C. elegans as a versatile platform for systematic dissection of the molecular basis of human disease, focusing on neurodegenerative disorders.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 31951916     DOI: 10.1016/j.copbio.2019.12.011

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  14 in total

1.  Wormicloud: a new text summarization tool based on word clouds to explore the C. elegans literature.

Authors:  Valerio Arnaboldi; Jaehyoung Cho; Paul W Sternberg
Journal:  Database (Oxford)       Date:  2021-03-31       Impact factor: 3.451

2.  Nanoparticles To Study Lectins in Caenorhabditis elegans: Multivalent Galactose β1-4 Fucose-Functionalized Dendrimers Provide Protection from Oxidative Stress.

Authors:  Harrison W VanKoten; Rebecca S Moore; Mary J Cloninger
Journal:  Biomacromolecules       Date:  2021-10-27       Impact factor: 6.988

Review 3.  Lipid metabolism and ageing in Caenorhabditis elegans: a complex interplay.

Authors:  Teresa Rubio-Tomás; Nektarios Tavernarakis
Journal:  Biogerontology       Date:  2022-09-01       Impact factor: 4.284

Review 4.  Translational relevance of forward genetic screens in animal models for the study of psychiatric disease.

Authors:  Eva Sheardown; Aleksandra M Mech; Maria Elena Miletto Petrazzini; Adele Leggieri; Agnieszka Gidziela; Saeedeh Hosseinian; Ian M Sealy; Jose V Torres-Perez; Elisabeth M Busch-Nentwich; Margherita Malanchini; Caroline H Brennan
Journal:  Neurosci Biobehav Rev       Date:  2022-02-04       Impact factor: 9.052

Review 5.  Biomedical and societal impacts of in vitro embryo models of mammalian development.

Authors:  Naomi Moris; Cantas Alev; Martin Pera; Alfonso Martinez Arias
Journal:  Stem Cell Reports       Date:  2021-05-11       Impact factor: 7.765

Review 6.  C. elegans Models to Study the Propagation of Prions and Prion-Like Proteins.

Authors:  Carl Alexander Sandhof; Simon Oliver Hoppe; Jessica Tittelmeier; Carmen Nussbaum-Krammer
Journal:  Biomolecules       Date:  2020-08-15

7.  The CONJUDOR pipeline for multiplexed knockdown of gene pairs identifies RBBP-5 as a germ cell reprogramming barrier in C. elegans.

Authors:  Marlon Kazmierczak; Carlota Farré I Díaz; Andreas Ofenbauer; Sergej Herzog; Baris Tursun
Journal:  Nucleic Acids Res       Date:  2021-02-26       Impact factor: 16.971

Review 8.  Molecular Basis of Neuronal Autophagy in Ageing: Insights from Caenorhabditis elegans.

Authors:  Georgios Konstantinidis; Nektarios Tavernarakis
Journal:  Cells       Date:  2021-03-21       Impact factor: 6.600

9.  Health and longevity studies in C. elegans: the "healthy worm database" reveals strengths, weaknesses and gaps of test compound-based studies.

Authors:  Nadine Saul; Steffen Möller; Francesca Cirulli; Alessandra Berry; Walter Luyten; Georg Fuellen
Journal:  Biogerontology       Date:  2021-03-08       Impact factor: 4.277

Review 10.  MUT-7 Provides Molecular Insight into the Werner Syndrome Exonuclease.

Authors:  Tsung-Yuan Hsu; Ling-Nung Hsu; Shih-Yu Chen; Bi-Tzen Juang
Journal:  Cells       Date:  2021-12-08       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.